相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?
Javier Blesa et al.
NATURE REVIEWS NEUROSCIENCE (2022)
LRRK2 and idiopathic Parkinson's disease
Emily M. Rocha et al.
TRENDS IN NEUROSCIENCES (2022)
Integrating deep learning and unbiased automated high-content screening to identify complex disease signatures in human fibroblasts
Lauren Schiff et al.
NATURE COMMUNICATIONS (2022)
DOME: recommendations for supervised machine learning validation in biology
Ian Walsh et al.
NATURE METHODS (2021)
iPSC modeling of young-onset Parkinson's disease reveals a molecular signature of disease and novel therapeutic candidates
A. H. Laperle et al.
NATURE MEDICINE (2020)
Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
Akihiro Yamaguchi et al.
STEM CELL REPORTS (2020)
Kinase inhibition of G2019S-LRRK2 enhances autolysosome formation and function to reduce endogenous alpha-synuclein intracellular inclusions
Julia Obergasteiger et al.
CELL DEATH DISCOVERY (2020)
Induced pluripotent stem cell-based modeling of mutant LRRK2-associated Parkinson's disease
Beatrice Weykopf et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2019)
LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease
Fiona Bonello et al.
HUMAN MOLECULAR GENETICS (2019)
Drug screening for human genetic diseases using iPSC models
Matthew S. Elitt et al.
HUMAN MOLECULAR GENETICS (2018)
T-type Calcium Channels Determine the Vulnerability of Dopaminergic Neurons to Mitochondrial Stress in Familial Parkinson Disease
Yoshikuni Tabata et al.
STEM CELL REPORTS (2018)
iPS cells in the study of PD molecular pathogenesis
Melanie M. Cobb et al.
CELL AND TISSUE RESEARCH (2018)
Decreased Sirtuin Deacetylase Activity in LRRK2 G2019S iPSC-Derived Dopaminergic Neurons
Andrew J. Schwab et al.
STEM CELL REPORTS (2017)
Parkinson disease
Werner Poewe et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice
Francesco Longo et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)
Overexpression of Parkinson's Disease-Associated Mutation LRRK2 G2019S in Mouse Forebrain Induces Behavioral Deficits and α-Synuclein Pathology
Yulan Xiong et al.
ENEURO (2017)
Functional Impairment in Miro Degradation and Mitophagy Is a Shared Feature in Familial and Sporadic Parkinson's Disease
Chung-Han Hsieh et al.
CELL STEM CELL (2016)
G2019S-LRRK2 Expression Augments α-Synuclein Sequestration into Inclusions in Neurons
Laura A. Volpicelli-Daley et al.
JOURNAL OF NEUROSCIENCE (2016)
Multiplexed high-content analysis of mitochondrial morphofunction using live-cell microscopy
Eligio F. Iannetti et al.
NATURE PROTOCOLS (2016)
Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases
Martin Steger et al.
ELIFE (2016)
Abrogation of α-synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats
Joao P. L. Daher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Isogenic Human iPSC Parkinson's Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription
Scott D. Ryan et al.
CELL (2013)
Ser1292 Autophosphorylation Is an Indicator of LRRK2 Kinase Activity and Contributes to the Cellular Effects of PD Mutations
Zejuan Sheng et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Clinical Features, with Video Documentation, of the Original Familial Lewy Body Parkinsonism Caused By α-Synuclein Triplication (Iowa Kindred)
Katrina Gwinn et al.
MOVEMENT DISORDERS (2011)
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease
Sonja Kriks et al.
NATURE (2011)
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
Michael J. Devine et al.
NATURE COMMUNICATIONS (2011)
Kinase activity of mutant LRRK2 mediates neuronal toxicity
Wanli W. Smith et al.
NATURE NEUROSCIENCE (2006)
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
AB West et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC
P Hampson et al.
BLOOD (2005)
分享论文
